ACADIA PHARMACEUTICALS INC — Director's Dealing 2018

Oct 24, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2018-10-15

Reporting Person: Stankovic Srdjan R. (EVP)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-15	Stock Option (right to buy)	$21.28	A	47500	Acquired	2028-10-15	Common Stock (47500)	Direct
2018-10-15	Restricted Stock Units	$	A	11875	Acquired		Common Stock (11875)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vest and become exercisable on October 15, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.

F2: Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.

F3: The restricted stock units vest in four equal annual installments beginning October 15, 2019.